Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2013

01-07-2013 | Paradigm Shifts in Perspective

Introduction to the “Paradigm Shifts in Perspective” Series

Author: Jonathan D. Kaunitz

Published in: Digestive Diseases and Sciences | Issue 7/2013

Login to get access

Excerpt

The history of human knowledge has so uninterruptedly shown that to collateral, or incidental, or accidental events we are indebted for the most numerous and most valuable discoveries, that it has at length become necessary, in any prospective view of improvement, to make not only large, but the largest allowances for inventions that shall arise by chance, and quite out of the range of ordinary expectation.
—Edgar Allan Poe, The Mystery of Marie Rogêt, 1842
These words, voiced by Auguste Dupin, a fictional amateur sleuth, contain an inalienable truth regarding the nature of discovery. In science, the truly major advances, which substantially change the way we think, termed “paradigm shifts” [1], often arise from the most unexpected quarters by individuals not considered to be in the mainstream of investigators associated with a disease or observation. With this issue, Digestive Diseases and Sciences introduces a new series of articles entitled “Paradigm Shifts in Perspective” which is aimed at highlighting scientific findings that have had a major impact on the field of gastroenterology. One of the motivations for creating this series is to increase the appreciation for “small” science, driven mostly by intellectual curiosity informed by a desire to understand disease pathogenesis, the principal wellspring for these advances. We plan to highlight advances that were initially under-appreciated, scorned, or even forgotten, only to resurface or gain acceptance as the “game changers” of gastroenterology. Since it can take decades for the full import of a discovery to manifest, most of the articles highlighted will be from the 1980s at the latest. …
Literature
1.
go back to reference Kuhn TS. The Structure of Scientific Revolutions. Chicago: University of Chicago Press; 1962. Kuhn TS. The Structure of Scientific Revolutions. Chicago: University of Chicago Press; 1962.
2.
go back to reference Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal permeability in patients with Crohn’s disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986;105:883–885.PubMedCrossRef Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal permeability in patients with Crohn’s disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986;105:883–885.PubMedCrossRef
3.
go back to reference D’Incà R, Annese V, di Leo V, et al. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1455–1461.PubMedCrossRef D’Incà R, Annese V, di Leo V, et al. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1455–1461.PubMedCrossRef
4.
go back to reference Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? Gut. 2006;55:342–347.PubMedCrossRef Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? Gut. 2006;55:342–347.PubMedCrossRef
Metadata
Title
Introduction to the “Paradigm Shifts in Perspective” Series
Author
Jonathan D. Kaunitz
Publication date
01-07-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2729-3

Other articles of this Issue 7/2013

Digestive Diseases and Sciences 7/2013 Go to the issue

Stanford Multidisciplinary Seminars

Always a Suspect: CMV in Ulcerative Colitis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine